{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:33:51Z","timestamp":1765812831738,"version":"3.48.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ek0109588"],"award-info":[{"award-number":["24ek0109588"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K10658"],"award-info":[{"award-number":["24K10658"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00415-025-13509-y","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:24:35Z","timestamp":1763555075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic impact of leuprorelin acetate on spinal and bulbar muscular atrophy: pre- and post-marketing observational study"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3098-7390","authenticated-orcid":false,"given":"Atsushi","family":"Hashizume","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Hanazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Komori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayano","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-9311","authenticated-orcid":false,"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"13509_CR1","first-page":"671","volume":"18","author":"WR Kennedy","year":"1968","unstructured":"Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. Sex Link Recess Trait Neurol 18:671\u2013680","journal-title":"Sex Link Recess Trait Neurol"},{"key":"13509_CR2","first-page":"209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A (1989) X-linked recessive bulbospinal neuronopathy. Clinicopathol Study Brain 112:209\u2013232","journal-title":"Clinicopathol Study Brain"},{"key":"13509_CR3","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1001\/archneur.59.12.1921","volume":"59","author":"AD Sperfeld","year":"2002","unstructured":"Sperfeld AD, Karitzky J, Brummer D, Schreiber H, H\u00e4ussler J, Ludolph AC et al (2002) X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 59:1921\u20131926","journal-title":"Arch Neurol"},{"key":"13509_CR4","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1212\/WNL.0000000000201342","volume":"100","author":"R Torii","year":"2023","unstructured":"Torii R, Hashizume A, Yamada S, Ito D, Kishimoto Y, Moriyoshi H et al (2023) Clinical features of female carriers and prodromal male patients with spinal and bulbar muscular atrophy. Neurology 100:e84\u2013e93","journal-title":"Neurology"},{"key":"13509_CR5","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/brain\/awl096","volume":"129","author":"N Atsuta","year":"2006","unstructured":"Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M et al (2006) Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 129:1446\u20131455","journal-title":"Brain"},{"key":"13509_CR6","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1093\/brain\/aws170","volume":"135","author":"A Hashizume","year":"2012","unstructured":"Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Mano T et al (2012) Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain 135:2838\u20132848","journal-title":"Brain"},{"key":"13509_CR7","doi-asserted-by":"publisher","first-page":"e1501","DOI":"10.1212\/WNL.0000000000005360","volume":"90","author":"Y Hijikata","year":"2018","unstructured":"Hijikata Y, Hashizume A, Yamada S, Inagaki T, Ito D, Hirakawa A et al (2018) Biomarker-based analysis of preclinical progression in spinal and bulbar muscular atrophy. Neurology 90:e1501\u2013e1509","journal-title":"Neurology"},{"key":"13509_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77\u201379","journal-title":"Nature"},{"key":"13509_CR9","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/jnnp-2020-322949","volume":"91","author":"A Hashizume","year":"2020","unstructured":"Hashizume A, Fischbeck KH, Pennuto M, Fratta P, Katsuno M (2020) Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA). J Neurol Neurosurg Psychiatry 91:1085\u20131091","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13509_CR10","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/brain\/awad050","volume":"146","author":"M Zanovello","year":"2023","unstructured":"Zanovello M, Ib\u00e1\u00f1ez K, Brown AL, Sivakumar P, Bombaci A, Santos L et al (2023) Unexpected frequency of the pathogenic AR CAG repeat expansion in the general population. Brain 146:2723\u20132729","journal-title":"Brain"},{"key":"13509_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/ana.410320517","volume":"32","author":"M Doyu","year":"1992","unstructured":"Doyu M, Sobue G, Mukai E, Kachi T, Yasuda T, Mitsuma T et al (1992) Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 32:707\u2013710","journal-title":"Ann Neurol"},{"key":"13509_CR12","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1212\/WNL.59.5.770","volume":"59","author":"BJ Schmidt","year":"2002","unstructured":"Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL (2002) Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59:770\u2013772","journal-title":"Neurology"},{"key":"13509_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1001\/archneurol.2011.2308","volume":"69","author":"M Katsuno","year":"2012","unstructured":"Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G (2012) Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy. Arch Neurol 69:436\u2013440","journal-title":"Arch Neurol"},{"key":"13509_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H et al (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35:843\u2013854","journal-title":"Neuron"},{"key":"13509_CR15","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","volume":"24","author":"ES Chevalier-Larsen","year":"2004","unstructured":"Chevalier-Larsen ES, O\u2019Brien CJ, Wang H, Jenkins SC, Holder L, Lieberman AP et al (2004) Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 24:4778\u20134786","journal-title":"J Neurosci"},{"key":"13509_CR16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M Katsuno","year":"2003","unstructured":"Katsuno M, Adachi H, Doyu M, Minamiyama M, Sang L, Kobayashi Y et al (2003) Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 9:768\u2013773","journal-title":"Nat Med"},{"key":"13509_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.20735","volume":"59","author":"H Banno","year":"2006","unstructured":"Banno H, Adachi H, Katsuno M, Suzuki K, Atsuta N, Watanabe H et al (2006) Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Ann Neurol 59:520\u2013526","journal-title":"Ann Neurol"},{"key":"13509_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ana.21540","volume":"65","author":"H Banno","year":"2009","unstructured":"Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N et al (2009) Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 65:140\u2013150","journal-title":"Ann Neurol"},{"key":"13509_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","volume":"9","author":"M Katsuno","year":"2010","unstructured":"Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I et al (2010) Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:875\u2013884","journal-title":"Lancet Neurol"},{"key":"13509_CR20","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00415-019-09251-x","volume":"266","author":"A Hashizume","year":"2019","unstructured":"Hashizume A, Katsuno M, Suzuki K, Banno H, Takeuchi Y, Kawashima M et al (2019) Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials. J Neurol 266:1211\u20131221","journal-title":"J Neurol"},{"key":"13509_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.nmd.2015.03.008","volume":"25","author":"A Hashizume","year":"2015","unstructured":"Hashizume A, Katsuno M, Suzuki K, Banno H, Suga N, Mano T et al (2015) A functional scale for spinal and bulbar muscular atrophy: cross-sectional and longitudinal study. Neuromuscul Disord 25:554\u2013562","journal-title":"Neuromuscul Disord"},{"key":"13509_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/archneur.1996.00550020045014","volume":"53","author":"The ALS CNTF treatment study (ACTS) phase I-II Study Group","year":"1996","unstructured":"The ALS CNTF treatment study (ACTS) phase I-II Study Group (1996) The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 53:141\u2013147","journal-title":"Arch Neurol"},{"key":"13509_CR23","first-page":"346","volume":"53","author":"Y Ohashi","year":"2001","unstructured":"Ohashi Y, Tashiro K, Itoyama Y, Nakano I, Sobue G, Nakamura S et al (2001) Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS (ALSFRS-R) Japanese version. No To Shinkei 53:346\u2013355","journal-title":"No To Shinkei"},{"key":"13509_CR24","first-page":"999","volume":"48","author":"E Oda","year":"1996","unstructured":"Oda E, Ohashi Y, Tashiro K, Mizuno Y, Kowa H, Yanagisawa N (1996) Reliability and factorial structure of a rating scale for amyotrophic lateral sclerosis. No To Shinkei 48:999\u20131007","journal-title":"No To Shinkei"},{"key":"13509_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","volume":"10","author":"LE Fern\u00e1ndez-Rhodes","year":"2011","unstructured":"Fern\u00e1ndez-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, Jeffries NO et al (2011) Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 10:140\u2013147","journal-title":"Lancet Neurol"},{"key":"13509_CR26","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMp1401111","volume":"370","author":"S Schneeweiss","year":"2014","unstructured":"Schneeweiss S (2014) Learning from big health care data. N Engl J Med 370:2161\u20132163","journal-title":"N Engl J Med"},{"key":"13509_CR27","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","volume":"375","author":"RE Sherman","year":"2016","unstructured":"Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL et al (2016) Real-world evidence\u2014what is it and what can it tell us? N Engl J Med 375:2293\u20132297","journal-title":"N Engl J Med"},{"key":"13509_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.neuron.2014.10.023","volume":"84","author":"F Benedetti","year":"2014","unstructured":"Benedetti F (2014) Placebo effects: from the neurobiological paradigm to translational implications. Neuron 84:623\u2013637","journal-title":"Neuron"},{"key":"13509_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3923","volume":"12","author":"P Enck","year":"2013","unstructured":"Enck P, Bingel U, Schedlowski M, Rief W (2013) The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov 12:191\u2013204","journal-title":"Nat Rev Drug Discov"},{"key":"13509_CR30","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1001\/jama.2024.7741","volume":"331","author":"JD Issa","year":"2024","unstructured":"Issa JD, Kirsten BD (2024) Causal inference about the effects of interventions from observational studies in medical journals. JAMA 331:1845\u20131853","journal-title":"JAMA"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13509-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13509-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13509-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:30:28Z","timestamp":1765812628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13509-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["13509"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13509-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors\u2019 institution received payment from Takeda Pharmaceutical Company Limited for legally mandated post-marketing surveillance. No personal fees were received by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"772"}}